Jim Simons Editas Medicine, Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q3 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,277,400 shares of EDIT stock, worth $3.32 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,277,400

Previous 888,400 43.79%

Holding current value

$3.32 Million

Previous $1.95 Million 126.82%

% of portfolio

0.01%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$2.2 - $3.52 $855,800 - $1.37 Million	389,000 Added 43.79%	1,277,400 $4.43 Million
Q2 2025 Aug 13, 2025	SELL	$0.98 - $2.35 $141,673 - $339,727	-144,565 Reduced 14.0%	888,400 $1.95 Million
Q1 2025 May 14, 2025	SELL	$1.14 - $3.2 $476,615 - $1.34 Million	-418,084 Reduced 28.81%	1,032,965 $1.2 Million
Q4 2024 Feb 13, 2025	BUY	$1.2 - $3.76 $1.74 Million - $5.46 Million	1,451,049 New	1,451,049 $1.84 Million
Q2 2024 Aug 09, 2024	SELL	$4.67 - $7.28 $3.74 Million - $5.82 Million	-799,989 Reduced 89.04%	98,429 $459,000
Q1 2024 May 13, 2024	BUY	$7.03 - $11.07 $2.75 Million - $4.33 Million	391,018 Added 77.06%	898,418 $6.67 Million
Q4 2023 Feb 13, 2024	BUY	$6.25 - $11.11 $2.77 Million - $4.92 Million	442,900 Added 686.67%	507,400 $5.14 Million
Q3 2023 Nov 14, 2023	SELL	$6.92 - $9.31 $635,256 - $854,658	-91,800 Reduced 58.73%	64,500 $503,000
Q2 2023 Aug 11, 2023	BUY	$6.36 - $11.47 $994,068 - $1.79 Million	156,300 New	156,300 $1.29 Million
Q2 2022 Aug 12, 2022	SELL	$9.99 - $21.35 $9.02 Million - $19.3 Million	-903,400 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$14.08 - $27.63 $9.51 Million - $18.7 Million	675,300 Added 296.05%	903,400 $17.2 Million
Q4 2021 Feb 11, 2022	BUY	$26.55 - $40.57 $6.06 Million - $9.25 Million	228,100 New	228,100 $6.06 Million
Q3 2021 Nov 12, 2021	SELL	$39.27 - $72.94 $5.5 Million - $10.2 Million	-140,000 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$31.29 - $56.64 $9.89 Million - $17.9 Million	-315,927 Reduced 69.29%	140,000 $7.93 Million
Q1 2021 May 13, 2021	BUY	$39.71 - $90.58 $18.1 Million - $41.3 Million	455,927 New	455,927 $19.1 Million
Q4 2020 Feb 10, 2021	SELL	$27.07 - $84.35 $2.87 Million - $8.95 Million	-106,100 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$28.06 - $37.16 $2.64 Million - $3.49 Million	-94,000 Reduced 46.98%	106,100 $2.98 Million
Q2 2020 Aug 13, 2020	SELL	$18.5 - $34.34 $1.86 Million - $3.46 Million	-100,800 Reduced 33.5%	200,100 $5.92 Million
Q1 2020 May 14, 2020	BUY	$14.88 - $32.78 $3.26 Million - $7.17 Million	218,800 Added 266.5%	300,900 $5.97 Million
Q4 2019 Feb 13, 2020	BUY	$19.49 - $32.63 $1.6 Million - $2.68 Million	82,100 New	82,100 $2.43 Million
Q2 2019 Aug 12, 2019	SELL	$20.48 - $27.76 $7.61 Million - $10.3 Million	-371,400 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$19.43 - $26.41 $1.93 Million - $2.63 Million	99,400 Added 36.54%	371,400 $9.08 Million
Q4 2018 Feb 13, 2019	BUY	$18.19 - $31.79 $4.95 Million - $8.65 Million	272,000 New	272,000 $6.19 Million

Others Institutions Holding EDIT

# of Institutions

217

Shares Held

48M

Call Options Held

637K

Put Options Held

292K

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $179M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account